Turning Point Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/12/2022

Shares

48,759

Value ($000)

3,669

Weight

0.0%

2019 Q4 - 2022 Q2 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/12/2022	3,669	0.0%	48,759	6/30/2022
2022 Q1	5/16/2022	1,180	0.0%	43,963	3/31/2022
2021 Q4	2/14/2022	2,097	0.0%	43,963	12/31/2021
2021 Q3	11/15/2021	2,983	0.0%	44,909	9/30/2021
2021 Q2	8/16/2021	3,479	0.0%	44,587	6/30/2021
2021 Q1	5/14/2021	4,014	0.0%	42,438	3/31/2021
2020 Q4	3/1/2021	4,467	0.0%	36,661	12/31/2020
2020 Q3	11/13/2020	2,478	0.0%	28,361	9/30/2020
2020 Q2	8/14/2020	1,878	0.0%	29,083	6/30/2020
2020 Q1	5/15/2020	424	0.0%	9,500	3/31/2020
2019 Q4	2/14/2020	914	0.0%	14,678	12/31/2019